← Russell 3000 cross-section

BCPC BALCHEM CORP

Trailing twelve months to 2026-06-30 · as filed 2026-07-31, not restated
Materials

Scale

Market cap
$5.7bn
Revenue TTM
$1.1bn
Net income TTM
$164m
Free cash flow
Composite score
55.4
Sector rank
#1000

Valuation

P / E
34.7
EV / EBITDA
20.9
EV / sales
5.2
FCF yield
Earnings yield vs 10-yr
-1.85pp

Earnings yield vs 10-yr compares what the business earns per pound invested against the 4.73% a 10-year US Treasury note pays for no equity risk. Negative means you are paying up front for growth not yet delivered.

Quality and growth

Net margin
15.1%
EBITDA margin
24.8%
ROE
12.6%
ROIC
17.9%
Revenue growth
10.1%

Insider activity, last 90 days

Net open-market
$0.00m
Buyers
0
Sellers
0

Open-market purchases and sales only. Grants, option exercises, gifts and shares withheld for tax are excluded: they are how people are paid, not what they think.

What management said

The following tables summarize consolidated net sales by segment and business segment earnings from operations for the three and six months ended June 30, 2026 and 2025: Results of Operations - Three Months Ended June 30, 2026 and 2025 Net Earnings Net Sales • The increase in net sales within the Human Nutrition & Health segment for the second quarter of 2026 as compared to the second quarter of 2025 was driven by higher sales within both the nutrients business and the food ingredients and solutions businesses. …BALCHEM CORP, 10-Q, period ended 2026-06-30, filed 2026-07-31

Read the full passage →